MOTS-C

Mitochondrial-derived peptide

MOTS-C is a mitochondrial-derived peptide — a next-generation metabolic regulator originating from the mitochondrial genome — valued for its role in metabolic homeostasis, insulin sensitivity and cellular energy regulation, making it a key compound for healthy aging. Typical Course: A full course runs 12 weeks at a consistent dose (5–10mg) once daily in the morning, ideally before exercise on an empty stomach for metabolic effect. Most customers notice initial effects around week 3, with results peaking around week 8. What to Expect: Improved metabolic rate, better insulin sensitivity, enhanced exercise performance and improved longevity markers. Key benefits include a novel mitochondrial origin, dual metabolic and performance benefits, strong longevity research interest and a simple once-daily morning dose. Considerations & Safety: This is a relatively newer compound with less long-term data than other peptides, and blood glucose changes — including a risk of hypoglycaemia — are possible. Common side effects include injection site redness, post-administration fatigue, rare headache and blood glucose fluctuation. Seek medical attention immediately if you experience symptoms of hypoglycaemia (shakiness, sweating, confusion), signs of infection, or a severe systemic reaction.